Immunotherapy drug capable of eliminating tumors in some early-stage cancers: Study
(NEW YORK) -- A new study in the New England Journal of Medicine suggests that some people with early-stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab.In the study, 82 out of 103 participants responded so well... Read More.
